>Leoni’s restructuring plan becomes legally binding - The Regional Court of Nuremberg-Fürth dismissed all immediate appeals filed against the Restructuring Court of Nuremberg’s decision to confirm the plan. As a result, LEONI AG's restructuring plan is now legally binding. As already communicated, the restructuring court in Nuremberg had confirmed the restructuring plan on 21 June 2023 after it had been approved with the required majorities at a dedicated meeting on 3...
>Leoni achieved another milestone to implement its restructuring plan - LEO announced overnight that they have received the approval of the required majorities for their restructuring plan announced earlier this year (please see details below) at a court meeting convened for this purpose. This sets the path for the restructuring plan to become legally binding. However, LEO still needs the ruling of the Nuremberg Restructuring Court, which has announced that its ruling...
EQS-News: Leoni AG / Schlagwort(e): Unternehmensrestrukturierung Leoni AG: Öffentliche Bekanntmachung des gerichtlichen Erörterungs- und Abstimmungstermins 12.05.2023 / 16:10 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Im Namen des Restrukturierungsbeauftragten Dr. Hubert Ampferl erfolgt nachfolgende Veröffentlichung: LEONI AGNürnberg ISIN DE0005408884 WKN 540888Legal Entity Identifier (LEI): 5299002HNCMIUBHOMK35 Öffentliche Restrukturierungssache derLEONI AG, Marienstraße 7, 90402 Nürnberg, eingetragen im Handelsregist...
EQS-News: Leoni AG / Key word(s): Restructure of Company Leoni AG: Öffentliche Bekanntmachung des gerichtlichen Erörterungs- und Abstimmungstermins (German language only) 12.05.2023 / 16:10 CET/CEST The issuer is solely responsible for the content of this announcement. (only available in German language)Im Namen des Restrukturierungsbeauftragten Dr. Hubert Ampferl erfolgt nachfolgende Veröffentlichung: LEONI AGNürnberg ISIN DE0005408884 WKN 540888Legal Entity Identifier (LEI): 5299002HNCMIUBHOMK35 Öffentliche Restrukturierungssache derLEONI AG, Marienstraße 7, ...
In a market that is still recovering from stress on the banking sector, we have carried out a quantitative screening of the Stoxx 600, identifying 57 stocks that are most immune to the risk of a slowdown and an increase in the cost of credit for companies and households. Our research department analysts have Outperform ratings on 15 of those stocks. They are: “defensives” (Dassault Aviation), “balanced” (Volkswagen, Stellantis, Wacker Chemie, K+S AG, Solvay, Arkema Total Energies, Rep...
Dans un marché qui reste convalescent des stress sur le secteur bancaire, nous avons réalisé, au sein du Stoxx 600, un screening quantitatif permettant d’identifier 57 valeurs les plus immunes au risque d’un ralentissement et d’un renchérissement du crédit aux entreprises et aux ménages. Parmi celles-ci, 15 valeurs bénéficient d’une opinion « Surperformance » par les analystes de notre bureau d’étude : « défensives » (Dassault Aviation), « équilibrées » (Volkswagen, Stellantis, Wacker...
>LEO signed an agreement with its stakeholders - Following up on its earlier announcement 5 days ago, LEO has sent out an ad hoc yesterday, that they have agreed with their stakeholders on a financial restructuring concept. A corresponding implementation agreement was signed by the syndicate banks, Stefan Pierer and LEO. In addition, a significant number of borrower's note holders with a volume of € 168m have declared that they will join the concept as of 3 April 2023...
>An unpleasant update on refinancing negotiations - Leoni announced that it is in advanced negotiations with its financing parties (syndicate banks) and Mr. Stefan Pierer as strategic investor on a financial restructuring concept and expects to reach an agreement shortly. The restructuring concept will substantially reduce the company's debt and provide fresh liquidity, but as a final consequence also result in a delisting of Leoni AG. In the view of Leoni’s executive...
Avec un retour de la FDA attendu dans les prochaines semaines (T2 2023), l’approbation suivie du lancement commercial d’Uzedy (mdc-IRM) constituent le principal catalyseur pour le titre à court terme. Cette consécration marquera à la fois le passage de Medincell d’une biotech R&D à une société commerciale mais aussi crédibilisera d’autant plus sa plateforme BEPO pour l’obtention de nouveaux partenariats. La mise à jour de nos estimations d’Uzedy, en amont du verdict et du lancement, n...
With an announcement from the FDA due in the next few weeks (Q2 2023), the approval of Uzedy (mdc-IRM) followed by a commercial launch is the main trigger for the share in the short term. This consecration will mark Medincell’s shift from a R&D biotech to a commercial company and also boost the credibility of its BEPO platform accordingly with a view to new partnerships. The update to our estimates for Uzedy ahead of the verdict and the product’s launch leads us to adjust our target p...
>February registrations up 12.2% y-o-y - The ACEA this morning reported February passenger car registrations for the EU (EU+EFTA+UK) that came in at 902.7k units, +12% y-o-y, -1% m-o-m, +5% YTD. However February sales remain -15% below the 2020 level and -21% below 2019. Mass market: Renault the most dynamic in February, followed by VW - Volkswagen Group sold 235.4k units, +21% y-o-y, mainly driven by the Volkswagen brand which increased by 23% to 96...
>February registrations up 12.2% y-o-y - The ACEA this morning reported February passenger car registrations for the EU (EU+EFTA+UK) that came in at 902.7k units, +12% y-o-y, -1% m-o-m, +5% YTD. However February sales remain -15% below the 2020 level and -21% below 2019. Mass market: Renault the most dynamic in February, followed by VW - Volkswagen Group sold 235.4k units, +21% y-o-y, mainly driven by the Volkswagen brand which increased by 23% to 96...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.